CIK 0001650648 · Non-accelerated filer<br>Smaller reporting company
4D Molecular Therapeutics, Inc.
Sign in to watch- Ticker
- FDMT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 473506994
- Phone
- 5105052680
- Business address
- 5858 HORTON STREET #455, EMERYVILLE, CA, 94608
- Former names
- 4D Molecular Therapeutics Inc., 4D Molecular Therapeutics Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,724,648
- in 7 filings, $2.7M under 10b5-1 plans
Net −$2,724,648. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-17 | MILLIGAN JOHN F Director | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2026-06-17 | SBLENDORIO GLENN Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2026-06-17 | Chacko Jacob Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2026-06-01 | Kirn David See Remarks | Sale 10b5-1 | −1,922 | $10.02 | $19K | 1,057,231 |
| 2026-03-25 | Kirn David Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +750,000 | 750,000 | ||
| 2026-03-25 | Bizily Scott Chief Legal Officer | Grant or award · Stock Option (Right to Buy) | +217,000 | 217,000 | ||
| 2026-03-25 | Simms Christopher Paul See Remarks | Grant or award · Stock Option (Right to Buy) | +219,000 | 219,000 | ||
| 2026-03-20 | Gupta Ashoo VP, Finance and Controller | Option exercise | +865 | 47,224 | ||
| 2026-03-20 | Gupta Ashoo VP, Finance and Controller | Sale | −310 | $8.61 | $3K | 46,914 |
| 2026-03-20 | Gupta Ashoo VP, Finance and Controller | Option exercise | +221 | 47,135 | ||
| 2026-03-20 | Gupta Ashoo VP, Finance and Controller | Sale | −80 | $8.61 | $689 | 47,055 |
| 2026-03-20 | Gupta Ashoo VP, Finance and Controller | Option exercise · Restricted Stock Units | −865 | 12,119 | ||
| 2026-03-20 | Gupta Ashoo VP, Finance and Controller | Option exercise · Restricted Stock Units | −221 | 3,087 | ||
| 2026-01-05 | SBLENDORIO GLENN Director | Grant or award · Stock Option (Right to Buy) | +45,000 | 45,000 | ||
| 2025-12-20 | Gupta Ashoo VP, Finance and Controller | Option exercise | +866 | 46,528 | ||
| 2025-12-20 | Gupta Ashoo VP, Finance and Controller | Sale | −310 | $8.68 | $3K | 46,218 |
| 2025-12-20 | Gupta Ashoo VP, Finance and Controller | Option exercise | +220 | 46,438 | ||
| 2025-12-20 | Gupta Ashoo VP, Finance and Controller | Sale | −79 | $8.68 | $686 | 46,359 |
| 2025-12-20 | Gupta Ashoo VP, Finance and Controller | Option exercise · Restricted Stock Units | −866 | 12,984 | ||
| 2025-12-20 | Gupta Ashoo VP, Finance and Controller | Option exercise · Restricted Stock Units | −220 | 3,308 |
Page 3 of 16 · 319 trades